Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Blood
|
August 23, 2021
Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects
Lam T Khuat, Logan V Vick, Cordelia Dunai, et al.
Blood Advances
|
February 24, 2026
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis
Joseph M Tuscano, Tamer Othman, Paul Frankel, et al.
Blood Advances
|
November 10, 2025
A Phase I Study of Blinatumomab/Lenalidomide in Relapsed/Refractory B cell Lymphoma; Toxicity, Efficacy and Correlative Analysis
Joseph M Tuscano, Tamer Othman, Paul Frankel, et al.
Scientific Reports
|
October 16, 2024
Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease
Samuel Lessard, Pauline Rimmelé, Hui Ling, et al.
Ejhaem
|
July 18, 2022
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect<sup>®</sup> MDS/AML Disease Registry
Daniel A Pollyea, Tracy I George, Mehrdad Abedi, et al.
International Journal of Laboratory Hematology
|
November 21, 2020
Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes
Jay L Patel, Mehrdad Abedi, Christopher R Cogle, et al.
Transplantation and Cellular Therapy
|
April 22, 2023
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care
Benjamin Tomlinson, Marcos de Lima, Christopher R Cogle, et al.
Journal for Immunotherapy of Cancer
|
August 30, 2023
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
Bijal D Shah, Ryan D Cassaday, Jae H Park, et al.
Blood
|
April 7, 2021
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results
Bijal D Shah, Michael R Bishop, Olalekan O Oluwole, et al.
Leukemia
|
March 20, 2025
Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
Bijal D Shah, Ryan D Cassaday, Jae H Park, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Blood
|
August 23, 2021
Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects
Lam T Khuat, Logan V Vick, Cordelia Dunai, et al.
Blood Advances
|
February 24, 2026
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis
Joseph M Tuscano, Tamer Othman, Paul Frankel, et al.
Blood Advances
|
November 10, 2025
A Phase I Study of Blinatumomab/Lenalidomide in Relapsed/Refractory B cell Lymphoma; Toxicity, Efficacy and Correlative Analysis
Joseph M Tuscano, Tamer Othman, Paul Frankel, et al.
Scientific Reports
|
October 16, 2024
Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease
Samuel Lessard, Pauline Rimmelé, Hui Ling, et al.
Ejhaem
|
July 18, 2022
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect<sup>®</sup> MDS/AML Disease Registry
Daniel A Pollyea, Tracy I George, Mehrdad Abedi, et al.
International Journal of Laboratory Hematology
|
November 21, 2020
Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes
Jay L Patel, Mehrdad Abedi, Christopher R Cogle, et al.
Transplantation and Cellular Therapy
|
April 22, 2023
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care
Benjamin Tomlinson, Marcos de Lima, Christopher R Cogle, et al.
Journal for Immunotherapy of Cancer
|
August 30, 2023
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
Bijal D Shah, Ryan D Cassaday, Jae H Park, et al.
Blood
|
April 7, 2021
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results
Bijal D Shah, Michael R Bishop, Olalekan O Oluwole, et al.
Leukemia
|
March 20, 2025
Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
Bijal D Shah, Ryan D Cassaday, Jae H Park, et al.
Page
of 7